Rare clinical phenotype of filaminopathy presenting as restrictive cardiomyopathy and myopathy in childhood.
Childhood
Congenital myopathy
FLNC-associated phenotype
Genes
Mutation
Rare clinical phenotype
Restrictive cardiomyopathy
Unfavourable prognosis
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
14 09 2022
14 09 2022
Historique:
received:
02
03
2022
accepted:
13
08
2022
entrez:
14
9
2022
pubmed:
15
9
2022
medline:
17
9
2022
Statut:
epublish
Résumé
FLNC is one of the few genes associated with all types of cardiomyopathies, but it also underlies neuromuscular phenotype. The combination of concomitant neuromuscular and cardiac involvement is not often observed in filaminopathies and the impact of this on the disease prognosis has hitherto not been analyzed. Here we provide a detailed clinical, genetic, and structural prediction analysis of distinct FLNC-associated phenotypes based on twelve pediatric cases. They include early-onset restrictive cardiomyopathy (RCM) in association with congenital myopathy. In all patients the initial diagnosis was established during the first year of life and in five out of twelve (41.7%) patients the first symptoms were observed at birth. RCM was present in all patients, often in combination with septal defects. No ventricular arrhythmias were noted in any of the patients presented here. Myopathy was confirmed by neurological examination, electromyography, and morphological studies. Arthrogryposes was diagnosed in six patients and remained clinically meaningful with increasing age in three of them. One patient underwent successful heart transplantation at the age of 18 years and two patients are currently included in the waiting list for heart transplantation. Two died due to congestive heart failure. One patient had ICD instally as primary prevention of SCD. In ten out of twelve patients the disease was associated with missense variants and only in two cases loss of function variants were detected. In half of the described cases, an amino acid substitution A1186V, altering the structure of IgFLNc10, was found. The present description of twelve cases of early-onset restrictive cardiomyopathy with congenital myopathy and FLNC mutation, underlines a distinct unique phenotype that can be suggested as a separate clinical form of filaminopathies. Amino acid substitution A1186V, which was observed in half of the cases, defines a mutational hotspot for the reported combination of myopathy and cardiomyopathy. Several independent molecular mechanisms of FLNC mutations linked to filamin structure and function can explain the broad spectrum of FLNC-associated phenotypes. Early disease presentation and unfavorable prognosis of heart failure demanding heart transplantation make awareness of this clinical form of filaminopathy of great clinical importance.
Sections du résumé
BACKGROUND
FLNC is one of the few genes associated with all types of cardiomyopathies, but it also underlies neuromuscular phenotype. The combination of concomitant neuromuscular and cardiac involvement is not often observed in filaminopathies and the impact of this on the disease prognosis has hitherto not been analyzed.
RESULTS
Here we provide a detailed clinical, genetic, and structural prediction analysis of distinct FLNC-associated phenotypes based on twelve pediatric cases. They include early-onset restrictive cardiomyopathy (RCM) in association with congenital myopathy. In all patients the initial diagnosis was established during the first year of life and in five out of twelve (41.7%) patients the first symptoms were observed at birth. RCM was present in all patients, often in combination with septal defects. No ventricular arrhythmias were noted in any of the patients presented here. Myopathy was confirmed by neurological examination, electromyography, and morphological studies. Arthrogryposes was diagnosed in six patients and remained clinically meaningful with increasing age in three of them. One patient underwent successful heart transplantation at the age of 18 years and two patients are currently included in the waiting list for heart transplantation. Two died due to congestive heart failure. One patient had ICD instally as primary prevention of SCD. In ten out of twelve patients the disease was associated with missense variants and only in two cases loss of function variants were detected. In half of the described cases, an amino acid substitution A1186V, altering the structure of IgFLNc10, was found.
CONCLUSIONS
The present description of twelve cases of early-onset restrictive cardiomyopathy with congenital myopathy and FLNC mutation, underlines a distinct unique phenotype that can be suggested as a separate clinical form of filaminopathies. Amino acid substitution A1186V, which was observed in half of the cases, defines a mutational hotspot for the reported combination of myopathy and cardiomyopathy. Several independent molecular mechanisms of FLNC mutations linked to filamin structure and function can explain the broad spectrum of FLNC-associated phenotypes. Early disease presentation and unfavorable prognosis of heart failure demanding heart transplantation make awareness of this clinical form of filaminopathy of great clinical importance.
Identifiants
pubmed: 36104822
doi: 10.1186/s13023-022-02477-5
pii: 10.1186/s13023-022-02477-5
pmc: PMC9476594
doi:
Substances chimiques
Filamins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
358Informations de copyright
© 2022. The Author(s).
Références
Hum Mutat. 2018 Sep;39(9):1161-1172
pubmed: 29858533
J Neuropathol Exp Neurol. 2020 Aug 1;79(8):908-914
pubmed: 32607581
ESC Heart Fail. 2020 Aug;7(4):1430-1441
pubmed: 32285648
Neuromuscul Disord. 2017 Jan;27(1):73-77
pubmed: 27816332
Neurol Genet. 2021 May 18;7(3):e590
pubmed: 34235269
Eur J Hum Genet. 2009 May;17(5):656-63
pubmed: 19050726
Hum Mutat. 2020 Sep;41(9):1600-1614
pubmed: 32516863
JACC Basic Transl Sci. 2016 Aug;1(5):344-359
pubmed: 28008423
Int J Mol Sci. 2020 Apr 13;21(8):
pubmed: 32295012
PLoS One. 2017 Oct 26;12(10):e0186642
pubmed: 29073160
J Mol Biol. 2007 May 11;368(4):1011-23
pubmed: 17379241
Pediatr Cardiol. 2020 Jan;41(1):165-174
pubmed: 31712860
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Am J Hum Genet. 2011 Jun 10;88(6):729-740
pubmed: 21620354
J Mol Biol. 1997 Dec 12;274(4):530-45
pubmed: 9417933
J Cell Sci. 2008 May 1;121(Pt 9):1345-7
pubmed: 18434644
Genes (Basel). 2020 Oct 15;11(10):
pubmed: 33076350
Rev Neurol (Paris). 2016 Oct;172(10):594-606
pubmed: 27633507
Biomed Res Int. 2020 May 23;2020:2149342
pubmed: 32566668
PLoS One. 2016 May 25;11(5):e0155180
pubmed: 27223613
Hum Genome Var. 2016 Oct 13;3:16035
pubmed: 27790376
Int J Cardiol. 2020 May 15;307:101-108
pubmed: 31627847
J Neuromuscul Dis. 2017;4(1):1-15
pubmed: 28269794
Am J Hum Genet. 2016 Nov 3;99(5):1086-1105
pubmed: 27745833
J Mol Diagn. 2018 Jul;20(4):533-549
pubmed: 29792937
Muscle Nerve. 2012 Aug;46(2):275-82
pubmed: 22806379
J Am Coll Cardiol. 2016 Dec 6;68(22):2440-2451
pubmed: 27908349
Muscle Nerve. 2019 May;59(5):E33-E37
pubmed: 30734317
Circ Genom Precis Med. 2021 Feb;14(1):e003126
pubmed: 33325730
Mov Disord. 2016 Aug;31(8):1251-2
pubmed: 27392807
JAMA Cardiol. 2021 Aug 1;6(8):891-901
pubmed: 33978673
Autophagy. 2021 Sep;17(9):2494-2510
pubmed: 33030392
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Circ Genom Precis Med. 2019 Mar;12(3):e002388
pubmed: 30919686
Circ Cardiovasc Genet. 2017 Dec;10(6):
pubmed: 29212899
Clin Genet. 2019 Oct;96(4):317-329
pubmed: 31245841
EMBO J. 2007 Sep 5;26(17):3993-4004
pubmed: 17690686
Mol Cell. 2006 Feb 3;21(3):337-47
pubmed: 16455489
Brain. 2007 Dec;130(Pt 12):3250-64
pubmed: 18055494
Transl Pediatr. 2020 Feb;9(1):21-33
pubmed: 32154132
Circulation. 2012 Sep 4;126(10):1237-44
pubmed: 22843787
Mayo Clin Proc. 2019 May;94(5):906-913
pubmed: 30935706
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Hum Mutat. 2020 Jun;41(6):1091-1111
pubmed: 32112656
Hum Mutat. 2018 Dec;39(12):2083-2096
pubmed: 30260051
Neurology. 2019 Oct 8;93(15):673-674
pubmed: 31492720
Mol Med Rep. 2020 Jan;21(1):438-444
pubmed: 31746383
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Genet Test Mol Biomarkers. 2018 Jun;22(6):374-383
pubmed: 29924655
J Biol Chem. 2014 Mar 21;289(12):8588-98
pubmed: 24469451
Nat Commun. 2014 Oct 29;5:5326
pubmed: 25351925
Exp Cell Res. 2019 Oct 15;383(2):111539
pubmed: 31369751
Acta Neuropathol. 2013 Jan;125(1):33-46
pubmed: 23109048
J Muscle Res Cell Motil. 2021 Jun;42(2):381-397
pubmed: 33710525
Nucleic Acids Res. 2014 Jul;42(Web Server issue):W314-9
pubmed: 24829462
Am J Hum Genet. 2005 Aug;77(2):297-304
pubmed: 15929027
Hum Mutat. 2016 Mar;37(3):269-79
pubmed: 26666891
JACC Clin Electrophysiol. 2018 Apr;4(4):504-514
pubmed: 30067491
Neurology. 2011 Dec 13;77(24):2105-14
pubmed: 22131542
Heart. 2005 Sep;91(9):1199-202
pubmed: 16103558
J Clin Med. 2021 Feb 04;10(4):
pubmed: 33557094
Neuromuscul Disord. 2010 Jun;20(6):390-6
pubmed: 20417099